SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Mafia Stock Mobsta's Social Club (Bulls Board)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jmhollen who wrote (6439)10/22/2010 9:10:55 AM
From: xcentral1  Read Replies (1) of 6687
 
COOL! AND HERE'S ANOTHER ONE...
...."been down so long it looks like up to me...." Richard Farina '66

CBIS
CNBC, Discovery Channel and National Geographic to Cover Dr. Robert Melamede and Richard Cowan of Cannabis Science Whom are Speaking at 'The Marijuana Conference' in New York City on Oct. 25 & 26

COLORADO SPRINGS, Colo., Oct 21, 2010
- Cannabis Science, Inc. (OTC Bulletin Board: CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce the upcoming coverage by CNBC, Discovery Channel and National Geographic for the speaking engagement of Dr. Robert Melamede, Cannabis Science, Inc., President & CEO, along with panelist discussions with Richard Cowan, Cannabis Science, Inc., Director & CFO, at "The Marijuana Conference" in New York City.
The Marijuana Conference (www.TheMarijuanaConference.com), organized by Dealflow, will take place October 25 & 26. It is being called "the first non-biased event in the industry." It will "cover all of the business and investment issues, and the pros and cons of legalization, offering in-depth analysis from a wide array of experts."

Film crews from CNBC, Discovery Channel and National Geographic will be in attendance, and will be filming and using footage from the event in upcoming documentaries about the industry.

Dr. Melamede noted, "It is with great pleasure that I can participate in this convention. As November 2 approaches, this national exposure will help the greater cause of legalization of medical marijuana and the ending of decades of ignorance and unwarranted fear as the value of medical marijuana is rediscovered and supported by thousands of peer reviewed scientific articles and the personal experience of hundreds of thousands of medical marijuana users".

CNBC anchor Trish Regan has been added to the agenda as the moderator for the panel discussion titled "Entrepreneurial Vision: The Business of Marijuana". Richard Cowan, Cannabis Science CFO, will be one of the panelists.

Richard Cowan, Cannabis Science CFO, commented "This conference is an excellent opportunity to introduce Cannabis Science to the New York financial community."

Ms. Regan is the host of the CNBC documentary "Marijuana Inc." and the upcoming sequel. CNBC will be covering the event as part of the documentary.

Other speakers include:

Stephen D'Angelo, Executive Director, Harborside Health Center

Lester Grinspoon, MD, Associate Professor Emeritus of Psychiatry, Harvard Medical School

Trish Regan, CNBC Anchor, Host of "Marijuana Inc."

Andrea Barthwell, Former Deputy Director for Demand Reduction, Executive Office of The President

Jill Lamoureux, Boulder County Caregivers & CDS Management Services

Joel W. Hay, PhD, Professor of Pharmaceutical Economics & Policy, University of Southern California

Senator Joshua Miller (D), Rhode Island State Senate

Jeffrey A. Miron, Director of Undergraduate Studies, Department of Economics, Harvard University

David E. Smith MD. Founder, Haight Ashbury Free Medical Clinic

About Cannabis Science, Inc.

Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext